Abstract
Resveratrol is a phenolic compound that has been widely studied in the last years because of its extensive pharmacological properties. It also has physicochemical properties that are adequate for diffusion through the human skin. An analytical method by high performance liquid chromatography was developed and validated for its determination in transdermal emulsion, as well in receptor media and skin layers. The trans-resveratrol release kinetic followed the Higushi’s model (R2 = 0.9926) with steady-state diffusion flux and lag time of 138.5 µg cm–2 h–1 and 0.49 h, respectively. It showed a percentage at 64.96 % for permeation. Thus, the results suggest that the emulsion studied is a potential vehicle for transresveratrol administration by transdermal route.
Keywords: Ex vivo human skin permeation, high performance liquid chromatography, in vitro drug release, resveratrol, transdermal emulsion, validation studies.
Graphical Abstract
Current Drug Delivery
Title:Studies with Emulsion Containing trans-resveratrol: in vitro Release Profile and ex vivo Human Skin Permeation
Volume: 12 Issue: 2
Author(s): Priscila Aparecida de Almeida, Michele Campos Alves, Hudson Caetano Polonini, Stephane Lima Calixto, Tiago Brum Braga Gomes, Alexandre Augusto Barros Lataliza, Cristiano Dias da Silveira Ramos, Nadia Rezende Barbosa Raposo, Anderson de Oliveira Ferreira and Marcos Antonio Fernandes Brandao
Affiliation:
Keywords: Ex vivo human skin permeation, high performance liquid chromatography, in vitro drug release, resveratrol, transdermal emulsion, validation studies.
Abstract: Resveratrol is a phenolic compound that has been widely studied in the last years because of its extensive pharmacological properties. It also has physicochemical properties that are adequate for diffusion through the human skin. An analytical method by high performance liquid chromatography was developed and validated for its determination in transdermal emulsion, as well in receptor media and skin layers. The trans-resveratrol release kinetic followed the Higushi’s model (R2 = 0.9926) with steady-state diffusion flux and lag time of 138.5 µg cm–2 h–1 and 0.49 h, respectively. It showed a percentage at 64.96 % for permeation. Thus, the results suggest that the emulsion studied is a potential vehicle for transresveratrol administration by transdermal route.
Export Options
About this article
Cite this article as:
de Almeida Aparecida Priscila, Alves Campos Michele, Polonini Caetano Hudson, Calixto Lima Stephane, Braga Gomes Brum Tiago, Barros Lataliza Augusto Alexandre, da Silveira Ramos Dias Cristiano, Barbosa Raposo Rezende Nadia, Oliveira Ferreira de Anderson and Fernandes Brandao Antonio Marcos, Studies with Emulsion Containing trans-resveratrol: in vitro Release Profile and ex vivo Human Skin Permeation, Current Drug Delivery 2015; 12 (2) . https://dx.doi.org/10.2174/1567201812666150130161736
DOI https://dx.doi.org/10.2174/1567201812666150130161736 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alzheimers Disease: SPECT and PET Tracers for Beta-Amyloid Imaging
Current Alzheimer Research Lifelong Endocrine Fluctuations and Related Cognitive Disorders
Current Pharmaceutical Design Anti-Angiogenic Therapies for Children with Cancer
Current Cancer Drug Targets Natural Therapies of the Inflammatory Bowel Disease: The Case of Rutin and its Aglycone, Quercetin
Mini-Reviews in Medicinal Chemistry Dedicated Breast CT: Current Status and New Directions
Current Medical Imaging Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
Current Pharmaceutical Design Intracellular Aβ and its Pathological Role in Alzheimer’s Disease: Lessons from Cellular to Animal Models
Current Alzheimer Research Dibenzofurans from Lichens – A Pharmacological Overview
Current Topics in Medicinal Chemistry Pyrazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer - An <i>in-silico</i> approach
Current Drug Research Reviews Understanding the Potential Role and Delivery Approaches of Nitric Oxide in Chronic Wound Healing Management
Current Pharmaceutical Design Adamantane – A Lead Structure for Drugs in Clinical Practice
Current Medicinal Chemistry Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers
Current Molecular Pharmacology Powerful Technique to Test Selectivity of Agents Acting on Cardiac Ion Channels: The Action Potential Voltage-Clamp
Current Medicinal Chemistry MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation
Current Drug Targets Novel Anti-inflammatory Drugs from Marine Microbes
The Natural Products Journal In silico Strategies to Probe Stereoselective Interactions of Multidrug Resistant Transporter P-glycoprotein
Letters in Drug Design & Discovery Electrospinning for Bone Tissue Engineering
Recent Patents on Nanotechnology Recent Advances in Understanding and Exploiting the Activation of Anthracyclines by Formaldehyde
Current Medicinal Chemistry - Anti-Cancer Agents Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)